Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 204

1.

Bivalirudin versus heparin as an anticoagulant during extracorporeal membrane oxygenation: a case-control study.

Pieri M, Agracheva N, Bonaveglio E, Greco T, De Bonis M, Covello RD, Zangrillo A, Pappalardo F.

J Cardiothorac Vasc Anesth. 2013 Feb;27(1):30-4. doi: 10.1053/j.jvca.2012.07.019. Epub 2012 Oct 1.

PMID:
23036625
2.

Bivalirudin in pediatric patients maintained on extracorporeal life support.

Nagle EL, Dager WE, Duby JJ, Roberts AJ, Kenny LE, Murthy MS, Pretzlaff RK.

Pediatr Crit Care Med. 2013 May;14(4):e182-8. doi: 10.1097/PCC.0b013e31827200b6.

PMID:
23648880
3.

Correlation of bivalirudin dose with creatinine clearance during treatment of heparin-induced thrombocytopenia.

Runyan CL, Cabral KP, Riker RR, Redding D, May T, Seder DB, Savic M, Hedlund J, Abramson S, Fraser GL.

Pharmacotherapy. 2011 Sep;31(9):850-6. doi: 10.1592/phco.31.9.850.

PMID:
21923585
4.

Bivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenation.

Ranucci M, Ballotta A, Kandil H, Isgrò G, Carlucci C, Baryshnikova E, Pistuddi V; Surgical and Clinical Outcome Research Group.

Crit Care. 2011;15(6):R275. doi: 10.1186/cc10556. Epub 2011 Nov 20.

5.

Safety, efficacy, and dosing requirements of bivalirudin in patients with heparin-induced thrombocytopenia.

Kiser TH, Burch JC, Klem PM, Hassell KL.

Pharmacotherapy. 2008 Sep;28(9):1115-24. doi: 10.1592/phco.28.9.1115.

PMID:
18752382
6.

Bivalirudin dosing adjustments for reduced renal function with or without hemodialysis in the management of heparin-induced thrombocytopenia.

Tsu LV, Dager WE.

Ann Pharmacother. 2011 Oct;45(10):1185-92. doi: 10.1345/aph.1Q177. Epub 2011 Aug 31.

PMID:
21881032
7.

Bivalirudin in venovenous extracorporeal membrane oxygenation.

Jyoti A, Maheshwari A, Daniel E, Motihar A, Bhathiwal RS, Sharma D.

J Extra Corpor Technol. 2014 Mar;46(1):94-7.

9.

Bioline heparin-coated ECMO with bivalirudin anticoagulation in a patient with acute heparin-induced thrombocytopenia: the immune reaction appeared to continue unabated.

Pappalardo F, Maj G, Scandroglio A, Sampietro F, Zangrillo A, Koster A.

Perfusion. 2009 Mar;24(2):135-7. doi: 10.1177/0267659109106773.

PMID:
19654158
10.
11.

Bivalirudin versus unfractionated heparin for prevention of hemofilter occlusion during continuous renal replacement therapy.

Kiser TH, MacLaren R, Fish DN, Hassell KL, Teitelbaum I.

Pharmacotherapy. 2010 Nov;30(11):1117-26. doi: 10.1592/phco.30.11.1117.

PMID:
20973685
12.

Prefilter bivalirudin for preventing hemofilter occlusion in continuous renal replacement therapy.

Mueller SW, MacLaren R, Fish DN, Kiser TH.

Ann Pharmacother. 2009 Jul;43(7):1360-5. doi: 10.1345/aph.1M179. Epub 2009 Jul 7.

PMID:
19584380
13.

Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement: The Randomized BRAVO-3 Trial.

Dangas GD, Lefèvre T, Kupatt C, Tchetche D, Schäfer U, Dumonteil N, Webb JG, Colombo A, Windecker S, Ten Berg JM, Hildick-Smith D, Mehran R, Boekstegers P, Linke A, Tron C, Van Belle E, Asgar AW, Fach A, Jeger R, Sardella G, Hink HU, Husser O, Grube E, Deliargyris EN, Lechthaler I, Bernstein D, Wijngaard P, Anthopoulos P, Hengstenberg C; BRAVO-3 Investigators.

J Am Coll Cardiol. 2015 Dec 29;66(25):2860-8. doi: 10.1016/j.jacc.2015.10.003. Epub 2015 Oct 15.

PMID:
26477635
14.

Successful use of bivalirudin as anticoagulant for ECMO in a patient with acute HIT.

Koster A, Weng Y, Böttcher W, Gromann T, Kuppe H, Hetzer R.

Ann Thorac Surg. 2007 May;83(5):1865-7.

PMID:
17462416
15.

Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia.

Dang CH, Durkalski VL, Nappi JM.

Pharmacotherapy. 2006 Apr;26(4):461-8.

PMID:
16553503
16.

Anticoagulation for critically ill cardiac surgery patients: is primary bivalirudin the next step?

Pappalardo F, Agracheva N, Covello RD, Pieri M, De Bonis M, Calabrò MG, Koster A, Zangrillo A.

J Cardiothorac Vasc Anesth. 2014 Aug;28(4):1013-17. doi: 10.1053/j.jvca.2013.10.004. Epub 2014 Jan 18.

PMID:
24447496
17.

Bivalirudin versus heparin and protamine in off-pump coronary artery bypass surgery.

Merry AF, Raudkivi PJ, Middleton NG, McDougall JM, Nand P, Mills BP, Webber BJ, Frampton CM, White HD.

Ann Thorac Surg. 2004 Mar;77(3):925-31; discussion 931.

PMID:
14992900
18.

Efficacy and safety of argatroban and bivalirudine in patients with suspected heparin-induced thrombocytopenia.

Vo QA, Lin JK, Tong LM.

Ann Pharmacother. 2015 Feb;49(2):178-84. doi: 10.1177/1060028014562949. Epub 2014 Dec 16.

PMID:
25515865
19.

Successful use and dosing of bivalirudin after temporary total artificial heart implantation: a case series.

Crouch MA, Kasirajan V, Cahoon W, Katlaps GJ, Gunnerson KJ.

Pharmacotherapy. 2008 Nov;28(11):1413-20. doi: 10.1592/phco.28.11.1413.

PMID:
18957002
20.

Bivalirudin therapy is associated with improved clinical and economic outcomes in ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention: results from an observational database.

Pinto DS, Ogbonnaya A, Sherman SA, Tung P, Normand SL.

Circ Cardiovasc Qual Outcomes. 2012 Jan;5(1):52-61. doi: 10.1161/CIRCOUTCOMES.111.961938. Epub 2012 Jan 10.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk